syntofulvin 500mg tablets
codal synto ltd (0000003170) 33 theklas lysioti str,dorothea building,6th floor, lemesos, 3030, 51785 - griseofulvin - tablets - 500mg - griseofulvin (0000126078) 500mg - griseofulvin
syntofulvin 125mg tablets
codal synto ltd (0000003170) 33 theklas lysioti str,dorothea building,6th floor, lemesos, 3030, 51785 - griseofulvin - tablets - 125mg - griseofulvin (0000126078) 125mg - griseofulvin
viprolox 750mg film coated tablets
delorbis pharmaceuticals ltd - ciprofloxacin hydrochloride - film coated tablets - 750mg - 0086483489 - ciprofloxacin hydrochloride - 750 mg base - ciprofloxacin
zobral 5mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - levocetirizine dihydrochloride - film coated tablets - 5mg - levocetirizine dihydrochloride (8000001832) 5mg - levocetirizine
inbrija
acorda therapeutics ireland limited - λεβοντόπα - Νόσος του Πάρκινσον - Αντιπαρκινσονικά φάρμακα - inbrija ενδείκνυται για τη διαλείπουσα θεραπεία από επεισοδιακή κινητικές διακυμάνσεις (ΑΠΌ επεισόδια) σε ενήλικες ασθενείς με νόσο του Πάρκινσον (pd) που έλαβαν θεραπεία με λεβοντόπα/dopa-αποκαρβοξυλάση αναστολέα.
mentholatum deep heat cream
colep laupheim gmbh & co kg (0000009764) fockestrasse 12, laupheim, de-88471 - menthol racemic; eucalyptus oil; methyl salicylate; turpentine oil - cream - menthol racemic (8000002894) 5,91% w/w; eucalyptus oil (0008000484) 1,97% w/w; methyl salicylate (0000119368) 12,8% w/w; turpentine oil (0008006642) 1,47% w/w
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - Αντινεοπλασματικοί παράγοντες - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - Αντινεοπλασματικοί παράγοντες - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.